Advances in Biological Augmentation for Muscle and Tendon Repair: Regenerative and Reconstructive Approaches in Elite Sports Medicine
DOI:
https://doi.org/10.64784/274Keywords:
Biological augmentation, Muscle injury, Tendon injury, Regenerative medicine, Platelet-rich plasma, Mesenchymal stromal cells, Bone marrow aspirate concentrate, Exosomes, Biomaterials, Tissue engineering, Reconstructive surgery, Sports medicine, Rehabilitation, Return to play, Elite athletes.Abstract
Muscle and tendon injuries remain among the most common causes of functional impairment and time-loss in elite athletes, representing a significant challenge for reconstructive surgery, sports medicine, and rehabilitation. Conventional treatment approaches frequently restore anatomical continuity but may not completely reproduce the biological and biomechanical properties of healthy tissue, increasing the risk of delayed recovery and recurrent injury. In recent years, biological augmentation has emerged as a promising strategy to enhance tissue regeneration through modulation of inflammation, stimulation of angiogenesis, promotion of extracellular matrix remodeling, and improvement of collagen organization. This narrative review critically examined current scientific evidence regarding the biological basis, clinical applications, and therapeutic potential of platelet-rich plasma, bone marrow aspirate concentrate, mesenchymal stromal cells, extracellular vesicles, exosomes, biomaterials, and tissue-engineered constructs for the management of muscle and tendon injuries in elite athletes. Current evidence suggests that platelet-rich plasma remains the most extensively investigated biological intervention, whereas cell-based therapies, biomaterials, and exosome-derived approaches continue to demonstrate considerable regenerative potential despite requiring further clinical validation. The findings also emphasize that successful recovery depends not only on biological augmentation but also on accurate diagnosis, individualized patient selection, technically sound reconstructive procedures, structured rehabilitation, progressive mechanical loading, and multidisciplinary clinical management. Although regenerative medicine continues to evolve rapidly, methodological heterogeneity among available studies highlights the need for standardized treatment protocols and large multicenter clinical investigations. Overall, biological augmentation represents a valuable adjunct to contemporary reconstructive strategies, offering new opportunities to improve tissue healing, functional recovery, and safe return to competitive sport in elite athletes.
References
[1] B. Chalidis, P. Givissis, P. Papadopoulos, and C. Pitsilos, “Molecular and Biologic Effects of Platelet-Rich Plasma (PRP) in Ligament and Tendon Healing and Regeneration: A Systematic Review,” International Journal of Molecular Sciences, vol. 24, no. 3, Art. 2744, 2023.
[2] M. Zou, J. Wang, and Z. Shao, “Therapeutic Potential of Exosomes in Tendon and Tendon-Bone Healing: A Systematic Review of Preclinical Studies,” Journal of Functional Biomaterials, vol. 14, no. 6, Art. 299, 2023.
[3] Y. Xue, N. Riva, L. Zhao, J. Shieh, Y. Chin, A. Gatt, and J. J. Guo, “Recent Advances of Exosomes in Soft Tissue Injuries in Sports Medicine: A Critical Review on Biological and Biomaterial Applications,” Journal of Controlled Release, vol. 364, pp. 90–108, 2023.
[4] A. H. Sheth, D. M. McCulloch, and colaboradores, “Platelet-Rich Plasma for Sports-Related Muscle, Tendon and Ligament Injuries: An Umbrella Review,” Blood Transfusion, vol. 18, no. 5, pp. 344–355, 2020.
[5] G. Filardo, M. Kon, E. Kon, et al., “Platelet-Rich Plasma in Acute Muscle Injuries: An Umbrella Review and Meta-analysis of Return to Sport and Reinjury Outcomes,” Orthopaedic Journal of Sports Medicine, vol. 13, 2025.
[6] N. Maffulli, J. C. Longo, and G. Denaro, “Novel Approaches for the Management of Tendinopathy,” Journal of Bone and Joint Surgery, vol. 102, no. 14, pp. 1246–1258, 2020.
[7] A. D. Aicale, B. Tarantino, and N. Maffulli, “Overuse Injuries in Sport: A Comprehensive Overview,” Journal of Orthopaedic Surgery and Research, vol. 13, Art. 309, 2018.
[8] B. Järvinen, T. L. Järvinen, M. Kääriäinen, H. Kalimo, and M. Järvinen, “Muscle Injuries: Biology and Treatment,” American Journal of Sports Medicine, vol. 33, no. 5, pp. 745–764, 2005.
[9] N. Maffulli, L. Oliva, and G. Maffulli, “ISMuLT Guidelines for Muscle Injuries,” Muscles, Ligaments and Tendons Journal, vol. 9, no. 3, pp. 313–324, 2019.
[10] F. Della Villa, P. Mandelbaum, and colaboradores, “Return to Sport Following Muscle Injuries in Elite Athletes,” British Journal of Sports Medicine, vol. 56, no. 3, pp. 138–145, 2022.
[11] J. L. Dragoo, K. Wasterlain, A. Braun, and J. Nead, “Platelet-Rich Plasma as a Treatment for Patellar Tendinopathy: A Systematic Review,” American Journal of Sports Medicine, vol. 42, no. 3, pp. 610–618, 2014.
[12] M. Andia and N. Maffulli, “Platelet-Rich Plasma for Managing Pain and Inflammation in Osteoarthritis,” Nature Reviews Rheumatology, vol. 9, pp. 721–730, 2013.
[13] R. S. Aspenberg, “Biologics and Tissue Healing in Sports Medicine,” Acta Orthopaedica, vol. 91, no. 2, pp. 125–132, 2020.
[14] J. D. Rodeo, “Biologic Augmentation of Rotator Cuff Tendon Repair,” Journal of Shoulder and Elbow Surgery, vol. 28, no. 7, pp. 1281–1291, 2019.
[15] American College of Sports Medicine, “ACSM Position Stand: Prevention and Treatment of Sports Injuries,” Medicine & Science in Sports & Exercise, vol. 53, no. 11, pp. e383–e408, 2021.
[16] M. D. Warden, “Biologic Therapies in Sports Medicine,” Sports Medicine, vol. 51, Suppl. 1, pp. 15–28, 2021.
[17] G. Filardo, E. Kon, and colaboradores, “Regenerative Medicine for Tendon Disorders: State of the Art,” Knee Surgery, Sports Traumatology, Arthroscopy, vol. 26, no. 7, pp. 2040–2053, 2018.
[18] N. Maffulli, U. G. Longo, and V. Denaro, “Current Treatment Options for Tendinopathy,” Expert Opinion on Pharmacotherapy, vol. 11, no. 14, pp. 2177–2186, 2010.
[19] World Health Organization, Rehabilitation in Health Systems: Guide for Action, Geneva, Switzerland: WHO, 2019.
[20] World Health Organization, World Rehabilitation Alliance: Background and Strategic Priorities, Geneva, Switzerland: WHO, 2023.
